📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors. (2023)

First Author: Mainwaring OJ

Attributed to: Anticipatory medicine: Can we identify, predict, and target mechanisms of disease relapse in childhood medulloblastoma? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-36847-9

PubMed Identifier: 36869047

Publication URI: http://europepmc.org/abstract/MED/36869047

Type: Journal Article/Review

Volume: 14

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723